DERM - Guggenheim Healthcare Talks 11/18
Dermira to Participate in the Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day
Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that company management will participate in a fireside chat at the Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day on Monday, November 18, 2019 at 9:00 a.m. ET in New York, NY.
A live audio webcast and archive of the presentation will be available at http://investor.dermira.com.